FDA: Moderna COVID-19 Vaccine Is 94% Effective : Shots - Health News : NPR
Moderna COVID-19 Vaccine Office Hours: Pediatric and Adolescent Indications | Moderna, Inc.
Moderna failed to disclose federal support in vaccine patents, researchers say - The Washington Post
After a big year, Moderna becomes the third largest biotech employer based in Mass. - The Boston Globe
Moderna to partner with ElevateBio on CRISPR research
Moderna executives have cashed out $89M in shares this year
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine - The New York Times
Moderna shells out for CEO security as its COVID-19 vaccine grabs the spotlight | Fierce Pharma
How Moderna's coronavirus vaccine differs from Pfizer's | CNN
Moderna Therapeutics Clinical Manufacturing Facility, Norwood
Moderna's Steep COVID Vaccine Price: Corporate Greed or Capitalism? | MedPage Today
Moderna failed to disclose federal funding for patent applications, advocates say
Moderna gets further $472 million U.S. award for coronavirus vaccine development
Moderna vaccine: Here are some of the limitations India may face with Moderna and Pfizer's COVID vaccine - Neck-to-neck race | The Economic Times
Moderna joins Association of the British Pharmaceutical Industry
Selling stock at a clip, top Moderna doctor gets $1 million richer each week
COVID shots made Moderna biotech's biggest star, but what now? - The Boston Globe
Moderna, Novavax developing combined COVID-19, flu shots | CBC News
Moderna's Coronavirus Vaccine is 94% Effective, Early Data Shows
Moderna CEO says its COVID vaccine will not be ready before election - CBS News
Moderna considering creating an mRNA monkeypox vaccine amid growing demand for shots - ABC News
Moderna's mRNA Cancer Vaccine Shows Promise in Preliminary Study - WSJ
Moderna to seek emergency FDA authorization for coronavirus vaccine - POLITICO
Early Data Show Moderna's Coronavirus Vaccine Is 94.5% Effective - The New York Times
